Reply: Accurate predictor for liver disease progression in patients with DC/TBD.

Giri, Neelam; Niewisch, Marena R; Rosenberg, Philip S; Vittal, Anusha; Savage, Sharon A; Heller, Theo

Giri, Neelam; Niewisch, Marena R; Rosenberg, Philip S; Vittal, Anusha; Savage, Sharon A; Heller, Theo.

Affiliation

Giri N; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Niewisch MR; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Rosenberg PS; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vittal A; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Heller T; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Hepatology ; 2024 Jul 17.

Article in En | MEDLINE | ID: mdl-39024339

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hepatology Year: 2024 Document type: Article Affiliation country: Estados Unidos Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google